News

Nanostim, leadless pacemaker

There have been several advances in electrophysiology (EP) technologies this past year, many of which were highlighted during the Heart Rhythm Society (HRS) 2013 scientific sessions earlier this...

July 25, 2013 — The 2013 ESC (European Society of Cardiology) Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy, developed in collaboration with the European Heart Rhythm...

June 28, 2013 — St. Jude Medical Inc. announced CE mark approval of its next-generation quadripolar device, the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D).

Medtronic Inc. announced new data demonstrating that simultaneously pacing the lower chambers of the heart, or biventricular (BiV) pacing with a cardiac resynchronization therapy (CRT) device,...

The American College of Cardiology and the American Heart Association released an expanded clinical practice guideline for the management of patients with heart failure, updating definitions and...

The incremental mortality in implantable pacemaker and defibrillator recipients who experience a device infection, compared to patients without device infection, is substantial and persists for at...

New data from 100,438 patients with Boston Scientific implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds...

St. Jude Medical Inc. has received CE Mark approval of its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy...

Biotronik announced the U.S. Food and Drug Administration (FDA) granted approval for its Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D...

St. Jude Medical Inc., a global medical device company, has announced first enrollment of its MultiPoint Pacing clinical study to build upon its first- to-market Quadripolar Pacing System....

St. Jude Medical Inc. announced CE Mark approval and European launch of its Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P). This CRT-P system offers more pacing...

 Medtronic Inc. announced market release of the CardioGuide Implant System, a novel real-time navigation system for cardiac resynchronization therapy pacemakers and defibrillators (CRT-P and...

Toshiba, activation imaging, ACC, 2013

This is a roundup of some of the DAIC editor's choice of the most innovative new technologies showcased at ACC 2013, including products in the areas of interventional cardiology, patient...

Biotronik Iforia ICD/CRT-D CE-Approval

Biotronik received CE mark for its most advanced ICD/CRT-D (implantable cardioverter defibrillator/cardiac resynchronization therapy device) series. Iforia is the world’s first DF4 ICD/CRT-D...

Cardiobridge, VAD, heart pump, hemodynamic support

The Heart Failure 2013 LA meeting will include a showcase of several startup companies offering innovative new approaches to address heart and cardiovascular disease.

ACC HRS Appropriate Use Criteria ICDs CRTs

The American College of Cardiology (ACC) and Heart Rhythm Society (HRS), along with key specialty societies, released appropriate use criteria for implantable cardioverter-defibrillators (ICDs)...

Medtronic Inc. announced it has received CE mark and will begin the European launch of the Attain Performa portfolio of quadripolar leads.

In response to the astounding percentage of inappropriate and non-compliant ICD, CRT-P and CRT-D device implantations each year, Think Tank Medical has developed and released its CMS ICD...

The U.S. Food and Drug Administration (FDA) has cleared St. Jude Medical’s new version of its Merlin.net Patient Care Network (PCN). The secure, Internet-based remote care system is for...

Evia HF-T  Biotronik Pacemaker Cardiac Resynchronization Therapy

Biotronik announced that high profile medical centers across the country are implanting the new Evia HF-T triple-chamber cardiac resynchronization therapy (CRT) pacemaker.